Exploiting genomics in the search for new drugs

Details Exploiting genomics in the search for new drugs Exploiting genomics in the search for new drugs

2001-07-06

2003-02-25

Jones, W. Gary (Department: 1655)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S004000, C435S007100, C435S091200, C435S288200, C536S023100, C536S024300

Reexamination Certificate

active

06524800

ABSTRACT:

BACKGROUND OF THE INVENTION
Many biological functions are accomplished by altering the expression of various genes through transcriptional (e.g. through control of initiation, provision of RNA precursors, RNA processing, etc.) and/or translational control. For example, fundamental biological processes such as cell cycle, cell differentiation and cell death, are often characterized by the variations in the expression levels of groups of genes.
Changes in gene expression also are associated with pathogenesis. For example, the lack of sufficient expression of functional tumor suppressor genes and/or the over expression of oncogene/protooncogenes could lead to tumorgenesis (Marshall,
Cell,
64: 313-326 (1991); Weinberg, Science, 254: 1138-1146 (1991), incorporated herein by reference for all purposes). Thus, changes in the expression levels of particular genes (e.g. oncogenes or tumor suppressors) serve as signposts for the presence and progression of various diseases.
Often drugs are screened and prescreened for the ability to interact with a major target without regard to other effects the drugs have on cells. Often such other effects cause toxicity in the whole animal, which prevent the development and use of the potential drug. Therefore, there is a need in the art to develop a systematic approach to test and develop new drugs for their effects on cellular metabolism without relying on gross morphologic and phenotypic effects.
SUMMARY OF THE INVENTION
This invention provides methods and compositions for studying the complex relationships among drugs and genes. In some of its specific applications, this invention provides methods and compositions for detecting alternate targets for drug screening and development by monitoring the expression of genes affected by a drug or mutation.


REFERENCES:
patent: 5700637 (1997-12-01), Southern
patent: 5965352 (1999-10-01), Stoughton et al.
patent: 89/10977 (1989-11-01), None
patent: 97/10365 (1997-03-01), None
patent: 97/27317 (1997-07-01), None
patent: 97/29091 (1997-08-01), None
patent: 98/05335 (1998-02-01), None
Ecker et al., “Estimation of the chemosensitizing activity of modulators of multi-drug resistance via combined simultaneous analysis of sigmoidal-dose response curves”, J. Pharmacy and Pharmacology, vol. 49, pp. 305-309.
S. Fodor, “Massively parallel genomics”, Science, vol. 277, Jul. 1997, pp. 393-394.
Sedlak et al., “Gene Chip Technology Ready to Impact Diagnostic Markets”, Genetic Enginering News, Dec. 1997, pp. 1.
Lockhart et al., “Expression monitoring by hybridization to high-density oligonucleotide arrays”, Nature Biotechnology, vol. 14, Dec. 1996, pp. 1674-1680.
Schow et al., “Synthesis and Activity of 2,6,9-Trisubstituted Purines”, Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 21, pp. 2697-2702, 1997.
Konig et al., “The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bc1-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines”, Blood, vol. 90, No. 11, 1997, pp. 4307-4312.
De Azevedo et al., “Inhibition of cyclin-dependnet kinase by purine analogues Crystal Structure of human cdk2 complexed with rosovitine”, European Journal of Biochemestry, vol. 243, No. 1/02, 1997, pp. 518-526.
Norman et al., “A structure-based library approach to kinase inhibitors”, The Journal of the American Chemical Society, vol. 118, 1996, pp. 7430-7431.
Brooks et al., “CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation”, Journal of Biological Chemistry, vol. 272, No. 46, Nov. 1997, pp. 29207-29211.
Gray, “Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors”, Science, vol. 281, 1998, pp. 533-538.
Cabell et al., “Effects of Antihypertensive Drugs on Rat Tissue Antioxidant Enzyme Activities and Lipid Peroxidation Levels”, Biochemical Pharmacology, vol. 54, Jan. 1997, pp. 133-141.

Affiliated with

Also associated with

Rating

Exploiting genomics in the search for new drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Exploiting genomics in the search for new drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Exploiting genomics in the search for new drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3140834